Federated Investors Inc. PA raised its holdings in shares of Hudbay Minerals Inc (NYSE:HBM) (TSE:HBM) by 4.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 335,000 shares of the mining company’s stock after purchasing an additional 15,000 shares during the quarter. Federated Investors Inc. PA owned 0.13% of Hudbay Minerals worth $2,371,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also added to or reduced their stakes in HBM. Neuberger Berman Group LLC lifted its position in Hudbay Minerals by 78.7% during the first quarter. Neuberger Berman Group LLC now owns 19,794 shares of the mining company’s stock valued at $140,000 after purchasing an additional 8,718 shares during the last quarter. AMP Capital Investors Ltd bought a new position in Hudbay Minerals during the fourth quarter valued at $141,000. BlackRock Inc. lifted its position in Hudbay Minerals by 44.3% during the fourth quarter. BlackRock Inc. now owns 21,352 shares of the mining company’s stock valued at $188,000 after purchasing an additional 6,554 shares during the last quarter. Paloma Partners Management Co bought a new position in Hudbay Minerals during the fourth quarter valued at $204,000. Finally, LPL Financial LLC bought a new position in Hudbay Minerals during the fourth quarter valued at $243,000. Institutional investors and hedge funds own 63.44% of the company’s stock.
Best Medical Stocks To Watch For 2022: SM Energy Company(SM)
We are an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and condensate, natural gas, and natural gas liquids (also respectively referred to as "oil," "gas," and "NGLs" throughout the document) in onshore North America. We were founded in 1908 and incorporated in Delaware in 1915. Our initial public offering of common stock was in December 1992. Our common stock trades on the New York Stock Exchange under the ticker symbol "SM." Our principal offices are located at 1775 Sherman Street, Suite 1200, Denver, Colorado 80203, and our telephone number is (303) 861-8140. Strategy Our strategic objective is to profitably build our ownership and operatorship of North American oil, gas, and NGL producing assets that have high operating margins and significant opportunities for additional economic investment. Advisors' Opinion:
- [By Motley Fool Transcribers]
SM Energy Co (NYSE:SM)Q4 2019 Earnings Conference CallFeb. 21, 2019, 10:00 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Logan Wallace]
Scotia Howard Weill upgraded shares of SM Energy (NYSE:SM) from a sector perform rating to a sector outperform rating in a research note published on Thursday morning.
- [By Max Byerly]
SM Energy Co (NYSE:SM) has received an average recommendation of “Buy” from the twenty-four analysts that are covering the stock, Marketbeat Ratings reports. Eight research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $30.80.
- [By Ethan Ryder]
SM Energy Co (NYSE:SM) gapped up prior to trading on Tuesday . The stock had previously closed at $32.22, but opened at $32.20. SM Energy shares last traded at $31.49, with a volume of 60289 shares trading hands.
Best Medical Stocks To Watch For 2022: REGENXBIO Inc.(RGNX)
We are a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy. In AAV gene therapy, the viral genes are removed from the AAV, a small, non-pathogenic virus, creating a biological delivery vehicle called a vector. A therapeutic gene sequence is then inserted, creating a recombinant vector. Our proprietary AAV gene delivery platform (our NAV Technology Platform) consists of exclusive rights to over 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10 (NAV Vectors). Our mission is to transform the lives of patients suffering from severe diseases with significant unmet medical needs by developing and commercializing gene therapy products administered directly into the body, or in vivo, based on our NAV Technology Platform. Advisors' Opinion:
- [By Todd Campbell]
In this episode of The Motley Fool's Industry Focus: Healthcare, host Shannon Jones and Motley Fool contributor Todd Campbell explain why Roche and Biogen are buying these companies and if these acquisitions make Regenxbio (NASDAQ:RGNX) an M&A target, too. Tune in to learn:
- [By George Budwell, Chuck Saletta, and Todd Campbell]
Armed with this insight, we asked three of our Motley Fool contributors which top small-cap stocks have their attention right now. They named AcelRx Pharmaceuticals (NASDAQ:ACRX), Realogy Holdings (NYSE:RLGY), and Regenxbio Inc. (NASDAQ:RGNX). Read on to find out why.
- [By Motley Fool Transcribers]
Regenxbio Inc. (NASDAQ:RGNX)Q4 2018 Earnings Conference CallFeb. 27, 2019, 4:30 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
Best Medical Stocks To Watch For 2022: AMREP Corporation(AXR)
The Company1was organized in 1961 as an Oklahoma corporation and, through its subsidiaries, is primarily engaged in two business segments: the real estate business operated by AMREP Southwest Inc. ("AMREP Southwest") and its subsidiaries and the Fulfillment Services business operated by Palm Coast Data LLC ("Palm Coast") and its affiliates. Information concerning industry segments is set forth in Note 20 in the footnotes to the consolidated financial statements included in this annual report on Form 10-K. As of July 1, 2016, the Company employed approximately 455 full time employees. The Company's foreign sales and activities are not significant. Many of the amounts and percentages presented in this Part I have been rounded for convenience of presentation. All references in this Part I to 2016 and 2015 mean the Company's fiscal years ended April 30, 2016 and 2015, unless otherwise qualified. Advisors' Opinion:
- [By Stephan Byrd]
Zacks Investment Research lowered shares of Alexco Resource (NYSEAMERICAN:AXU) (TSE:AXR) from a hold rating to a sell rating in a research note released on Tuesday morning.
Best Medical Stocks To Watch For 2022: SandRidge Mississippian Trust II(SDR)
SandRidge Mississippian Trust II is a statutory trust formed under the Delaware Statutory Trust Act pursuant to a trust agreement by and among SandRidge, as Trustor, The Bank of New York Mellon Trust Company, N.A., as Trustee (the "Trustee"), and The Corporation Trust Company, as Delaware Trustee (the "Delaware Trustee"). The Trust's affairs are administered by the Trustee, which maintains its offices at 919 Congress Avenue, Austin, Texas 78701. The Trust does not have any employees. Copies of reports filed by the Trust under the Exchange Act are made available as soon as reasonably practicable after such materials are filed with or furnished to the Securities and Exchange Commission ("SEC"). Certain information concerning the Trust and Trust units as well as a link to the Trust's filings with the SEC may be obtained at the following website location: http://sandridgesdr.investorhq.businesswire.com/. Advisors' Opinion:
- [By Logan Wallace]
Shares of SCHRODERS/PAR VTG FPD 1 (LON:SDR) have earned a consensus recommendation of “Hold” from the ten research firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is GBX 3,576.11 ($46.73).
- [By Ethan Ryder]
Matador Resources (NYSE: MTDR) and SandRidge Mississippian Trust II (NYSE:SDR) are both oils/energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability.
Best Medical Stocks To Watch For 2022: ECA Marcellus Trust I(ECT)
ECA Marcellus Trust I owns royalty interests in producing and development horizontal natural gas wells for Energy Corporation of America (ECA). The company owns royalty interests in 14 producing horizontal natural gas wells producing from the Marcellus Shale formation located in Greene County, Pennsylvania; and 52 horizontal natural gas development wells drilled to the Marcellus Shale formation comprising approximately 9,300 acres held by ECA in Greene County, Pennsylvania. Its royalty interests in the producing wells allow the company to receive 90% of the proceeds from the sale of production of natural gas attributable to ECA's interest in the producing wells. The company's royalty interests in the development wells allow the company to receive 50% of the proceeds from the sale of production of natural gas attributable to ECA's interest in the development wells. ECA Marcellus Trust I was founded in 2010 and is based in Austin, Texas.
SuperEdge (CURRENCY:ECT) traded 1.3% higher against the dollar during the 1 day period ending at 21:00 PM Eastern on October 4th. One SuperEdge token can currently be purchased for $0.0001 or 0.00000002 BTC on major exchanges. Over the last week, SuperEdge has traded 13.3% higher against the dollar. SuperEdge has a market cap of $0.00 and $91.00 worth of SuperEdge was traded on exchanges in the last day. SuperEdge (CURRENCY:ECT) traded 17.2% higher against the dollar during the 24-hour period ending at 14:00 PM ET on September 22nd. One SuperEdge token can now be purchased for about $0.0001 or 0.00000001 BTC on cryptocurrency exchanges. In the last seven days, SuperEdge has traded 52.1% lower against the dollar. SuperEdge has a total market capitalization of $0.00 and approximately $623.00 worth of SuperEdge was traded on exchanges in the last day. SuperEdge (CURRENCY:ECT) traded 19.2% lower against the US dollar during the 24-hour period ending at 19:00 PM E.T. on September 1st. SuperEdge has a market capitalization of $0.00 and approximately $947.00 worth of SuperEdge was traded on exchanges in the last day. Over the last seven days, SuperEdge has traded up 2.2% against the US dollar. One SuperEdge token can now be purchased for approximately $0.0002 or 0.00000002 BTC on popular exchanges. Media coverage about Eca Marcellus Trust I (NYSE:ECT) has been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Eca Marcellus Trust I earned a coverage optimism score of 0.24 on Accern’s scale. Accern also assigned media coverage about the oil and gas company an impact score of 47.7651927822973 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days. First Midwest Bancorp, Inc. operates as a bank holding company for First Midwest Bank that provides various banking products and services. The company accepts various deposits, such as checking, NOW, money market, and savings accounts, as well as various types of short-term and long-term certificates of deposit. Its loan products include working capital loans and lines of credit; accounts receivable financing; inventory and equipment financing; sector-based lending, including leasing, healthcare, asset-based lending, structured finance, and syndications; agricultural loans; and mortgages, home equity lines and loans, personal loans, specialty loans, and auto loans. In addition, the company offers treasury management products and services comprising ACH collections, lockbox, remote deposit capture, and financial electronic data interchange; payables and payroll services, such as wire transfer, account reconciliation, controlled disbursement, direct deposit, and positive pay; information reporting services; corporate credit cards; and liquidity management, fraud prevention, and merchant services. Further, it provides wealth management services, such as investment management, fiduciary and executor, financial planning, employee benefit plans, and private banking services to corporate and public retirement plans, foundations and endowments, high net worth individuals, and multi-employer trust funds. Additionally, the company offers debit and automated teller machine, and credit cards; Internet and mobile, and telephone banking services; and financial education services. It serves commercial and industrial, commercial real estate, municipal, and consumer customers. The company operates 107 banking locations in Chicago metropolitan area, northwest Indiana, central and western Illinois, and eastern Iowa. First Midwest Bancorp, Inc. was founded in 1982 and is headquartered in Itasca, Illinois. Get a free copy of the Zacks research report on First Midwest Bancorp (FMBI) For more information about research offerings from Zacks Investment Research, visit Zacks.com Get a free copy of the Zacks research report on First Midwest Bancorp (FMBI) For more information about research offerings from Zacks Investment Research, visit Zacks.com Schwab Charles Investment Management Inc. increased its holdings in First Midwest Bancorp Inc (NASDAQ:FMBI) by 5.6% during the second quarter, Holdings Channel reports. The fund owned 622,052 shares of the financial services provider’s stock after acquiring an additional 32,814 shares during the quarter. Schwab Charles Investment Management Inc.’s holdings in First Midwest Bancorp were worth $15,844,000 as of its most recent SEC filing. Best Medical Stocks To Watch For 2022: First Midwest Bancorp, Inc.(FMBI)
No comments:
Post a Comment